DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Profit & Loss Account Balance History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Profit & Loss Account Balance | ₹15,370 Cr | ₹13,400 Cr | ₹11,786 Cr | ₹10,959 Cr | ₹9,989 Cr |
What is the latest Profit & Loss Account Balance ratio of DIVIS LABORATORIES ?
| Year | Profit & Loss Account Balance |
|---|---|
| Mar2026 | ₹15,370 Cr |
| Mar2025 | ₹13,400 Cr |
| Mar2024 | ₹11,786 Cr |
| Mar2023 | ₹10,959 Cr |
| Mar2022 | ₹9,989 Cr |
How is Profit & Loss Account Balance of DIVIS LABORATORIES Trending?
| Years | Profit & Loss Account Balance | % Change | |
|---|---|---|---|
| Mar2026 | ₹15,370 Cr | 14.70 | |
| Mar2025 | ₹13,400 Cr | 13.69 | |
| Mar2024 | ₹11,786 Cr | 7.55 | |
| Mar2023 | ₹10,959 Cr | 9.71 | |
| Mar2022 | ₹9,989 Cr | - | |
Compare Profit & Loss Account Balance of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹248,083.2 Cr | 1.6% | 9.3% | 54.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹442,437.0 Cr | -0.5% | -3% | 16% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,842.0 Cr | 3.5% | 2.3% | 40.6% | Stock Analytics | |
| CIPLA | ₹111,565.0 Cr | 1.6% | -3.2% | -11.1% | Stock Analytics | |
| MANKIND PHARMA | ₹102,410.0 Cr | 10.3% | 4.5% | -5.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,163.0 Cr | 5.8% | 3.2% | -8.3% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | 1.6% |
9.3% |
54.8% |
| SENSEX | 0.7% |
-3.9% |
-8.9% |
You may also like the below Video Courses